ISO factory supply ...

ISO factory supply 99% Lidocaine HCl 73-78-9
ISO factory supply 99% Lidocaine HCl 73-78-9
ISO factory supply 99% Lidocaine HCl 73-78-9
ISO factory supply 99% Lidocaine HCl 73-78-9

ISO factory supply 99% Lidocaine HCl 73-78-9

Min.Order / FOB Price:Get Latest Price

1 Kilogram

FOB Price: USD 35.0000

  • Min.Order :1 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,T/T,,MoneyGram,Other

Keywords

Lidocaine HCl Lidocaine hydrochloride 73-78-9

Quick Details

  • Appearance:powder
  • Application:Pharmaceutical Raw powder
  • PackAge:1kg/bag, 25kg/drum
  • ProductionCapacity:10000|Kilogram|Day
  • Storage:White crystalline powder
  • Transportation:by express, dhl,tnt,ems by air, by sea

Superiority:

Free sample, low freight, fast delivery, payment assurance, 24 hours service,high purity, good effect,good feedback, lead time:1-3 days, payment terms: TT, alibaba, , factory supplier, recruit overseas agents, welcome inquiry.

Details:

ISO factory supply 99% Lidocaine HCl 73-78-9

Product Name Lidocaine HCL
CAS NO. 73-78-9
Mol. Formula C14H25ClN2O2
MW 270.8
EINECS 604-158-7 
Appearance White crystalline powder
Purity  99%

Lidocaina hydrochlorida is dissolved in water and is generally used as a liquid. Lidocaina is not dissolved in water and is generally used as a cream.

Function of Lidocaine hydrochloride

1. Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.

2.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.
 

3. Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias if amiodarone is not available or contraindicated.
 

4. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View